Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Karin Conde"


2 mentions found


Or any of the blockbuster weight loss and diabetes drugs that recently caught the world’s attention? The joy of foodHolst is also very focused on this particular mechanism of the GLP-1 drugs but worries that it can go too far. For others, it is the loss of lean muscle mass that accompanies their weight loss and puts them at greater risk for falls. Because the medications work by slowing digestion, terrible constipation becomes a side effect that is too much for some to bear. There is little doubt that for most people, regular exercise and eating right is still the best strategy for weight loss and overall health.
Persons: Sanjay Gupta, Jens Juul Holst, Holst, CNN Holst, Karin Conde, ” Conde, Knape, , , Dr Organizations: CNN, Novo Nordisk, American Medical Association, World Health Organization, BMI, CNN Health Locations: Copenhagen, Danish, United States,
Patients taking blockbuster obesity drugs Ozempic or Wegovy will pack the pounds back on after they stop taking the medications. Studies have similarly shown weight rebound in people who stop taking Ozempic. So has Ozempic, which was first authorized to treat diabetes and is now being used off-label for weight loss. The shortage and other factors like out-of-pocket costs without insurance or unpleasant side effects have forced some people to stop taking Ozempic or Wegovy. Conde-Knape said so far data indicate that weight loss is maintained with long-term use of the drugs.
Total: 2